Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the semaglutides market right now?

In recent times, the semaglutides market has experienced significant growth. It is projected to expand from $23.07 billion in 2024 to $26 billion in 2025, with a compound annual growth rate (CAGR) of 12.7%. The historic growth can be linked to lifestyle alterations leading to a rise in diabetes, an upsurge in research and development investment, increased healthcare spending, the growth of pharmaceutical establishments in emerging regions, and a heightened approval towards injectable treatments.

How fast Is the semaglutides market expected to grow, and what’s its future value?

The semaglutides market size is expected to see rapid growth in the next few years. It will grow to $41.4 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing prevalence of diabetes globally, rising awareness about diabetes management and treatment, growing demand for effective therapies with fewer side effects, government initiatives and policies supporting diabetes treatment, aging population leading to higher diabetes incidence. Major trends in the forecast period include digital health integration, integration of artificial intelligence and machine learning, demand for telemedicine and remote monitoring, development of wearable technology, demand for 3D printing, use of blockchain for supply chain management.

Get your semaglutides market report here!

https://www.thebusinessresearchcompany.com/report/semaglutides-global-market-report

What are the leading drivers of growth in the semaglutides market?

The escalating occurrence of diabetes is anticipated to spur the expansion of the semaglutide market. Diabetes, a persistent condition marked by heightened blood glucose levels, stems from the body’s incapability to generate or efficiently utilize insulin. Factors promoting the rise in diabetes cases encompass increasing obesity rates, inactive lifestyles, and unhealthy diet patterns. Semaglutide comes in useful for diabetes treatment by replicating the GLP-1 hormone, which amplifies insulin secretion, curtails glucagon release, and decelerates gastric emptying. This process mitigates blood glucose levels and aids in shedding weight. Notably, in February 2023, as per Diabetes Canada, a Canada-situated non-profit organization, it was reported that 2.4 million Canadians were either prediabetic or diabetic. This figure is expected to swell up to 3 million by 2033. Consequently, the rising incidence of diabetes is fuelling the growth of the semaglutide market.

What are the key segments defining the semaglutides market?

The semaglutides market covered in this report is segmented –

1) By Brands: Ozempic, Wegovy, Rybelsus

2) By Route Of Administration: Oral, Injection

3) By Application: Type 2 Diabetes, Obesity Management

4) By End-User: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Ozempic: Pen Injection (Auto-Injector), Prefilled Pens (Dosages 0.25mg, 0.5mg, 1mg, 2mg)

2) By Wegovy: Subcutaneous Injection (Auto-Injector), Prefilled Pens (Dosages 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg)

3) By Rybelsus: Oral Tablets (Dosages Of 3mg, 7mg, 14mg)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18720&type=smp

Who are the key players steering the development of the semaglutides market?

Major companies operating in the semaglutides market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Biocon Limited, Hanmi Pharmaceutical Co. Ltd., Intarcia Therapeutics Inc., Adocia SA

What key trends are currently impacting the semaglutides market’s development?

Companies prominent in the semaglutides market are concentrating on the innovation of products such as GLP-1 receptor analogue, in order to boost the effectiveness of treatments for diabetes and obesity, optimise patient compliance, and minimize side effects through sophisticated delivery systems and customised medication regimes. GLP-1 receptor analogue is an engineered peptide tailored to imitate glucagon-like peptide-1 (GLP-1) functions, which ameliorates insulin secretion and governs blood glucose levels in diabetes care. Taking an example in January 2022, Novo Nordisk India, a firm based in India known for its pharmaceutical products and services, introduced oral semaglutide, bringing a major change in diabetes management. Semaglutide, a GLP-1 receptor analogue (GLP-1 RA) employed for diabetes treatment, was formerly exclusively available as an injection. This occasion marks the debut of the drug being developed in an oral version. Oral semaglutide blends the GLP-1RA semaglutide with an absorption augmenter referred to as SNAC. This specific formula safeguards semaglutide from breaking down in the stomach, a typical issue for peptides, while simultaneously promoting its absorption.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18720

Which geographic areas are influencing the growth of the semaglutides market?

North America was the largest region in the semaglutides market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the semaglutides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Semi-Trailer Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/semi-trailer-global-market-report

Single-Use Assemblies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/single-use-assemblies-global-market-report

Semiconductor Etch Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/semiconductor-etch-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: